TiffaniKHamiltonMD
Dermatology • Alpharetta, GACosmetic Dermatology, Dermatologic Surgery, Dermatopathology
Hamilton Dermatology Atlanta Dermatology, Vein @ Research
Dr. Hamilton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11800 Atlantis Pl
Alpharetta, GA 30022Phone+1 770-360-8881Fax+1 770-255-2533
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Dermatology, 1995 - 1998
University of Utah HealthInternship, Internal Medicine, 1994 - 1995
University of Utah School of MedicineClass of 1994
Certifications & Licensure
GA State Medical License 1998 - 2025- American Board of Dermatology Dermatology
- CCIRegistered Vascular Specialist
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Start of enrollment: 2010 Sep 01
- This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
- A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Publications & Presentations
PubMed
- 405 citationsA novel targeted T-cell modulator, efalizumab, for plaque psoriasisMark Lebwohl, Stephen K. Tyring, Tiffani K. Hamilton, Darryl Toth, Scott Glazer
The New England Journal of Medicine. 2003-11-20 - 165 citationsEfficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.Alan Menter, Kenneth B. Gordon, Wayne D. Carey, Tiffani K. Hamilton, Scott Glazer
Archives of Dermatology. 2005-01-01 - 300 citationsEfalizumab for Patients with Moderate to Severe Plaque Psoriasis: A Randomized Controlled TrialKenneth B. Gordon, Kim A. Papp, Tiffani K. Hamilton, Patricia A. Walicke, Wolfgang Dummer
JAMA. 2003-12-17
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
